The biopharma industry has raised nearly $62 billion in the first six months of the year, bringing it very close to the $68 billion full-year record of 2015. Well over half of that money has been raised in just the last two months, with May collecting $23.4 billion and June pulling in $16.28 billion.

Biopharma money raised to-date and by quarter in 2020, including public, private and other financings.

Research focused on finding viable solutions to counter the COVID-19 pandemic continues at an explosive pace with a total of 588 potential therapeutics and vaccines at the forefront of scientific efforts launched by industry, academia and government.

The share prices of blue-chip biopharmaceutical companies closed out the month on a high note to contribute to their stellar collective performance during the second quarter, with the BioWorld Biopharmaceutical index increasing almost 20%.